Pakistan’s pharmaceutical sector is shifting from a domestic focus to becoming a high-value global player. At the Pak Pharma & Healthcare Expo 2026, top industry leaders and regulatory experts outlined the roadmap for export expansion:
Key Discussion Pillars:
Analytical Excellence: Elevating quality control to meet international benchmarks.
Digital Integration: Implementing smart compliance systems for global regulatory approvals.
Export Strategy: Identifying high-value markets for life-saving medicines.
Featured Insights From:
Dr. Tahir Azam (Chairman PPMA & CEO, Mega Pharmaceuticals Ltd)
Dr. Faisal Q. Khokhar (Executive Director, Remington Pharmaceuticals)
Mr. Hamid Raza (CEO, Neutro Pharma Pvt Ltd)
Dr. Asim Rauf (Former CEO, DRAP)
Mr. Ismail Mastoi (Director Plant Operations, McOLSON Research Laboratories)
Mr. Muhammad Arif Bilal (Director Plant, CSH Pharmaceuticals)
Dr. Rizwan Mahmood (Consultant, formerly GSK, Highnoon, CCL)
Hafiz Muhammad Umar Nisar (Quality Manager, Ameer & Adnan Pharmaceuticals)
The consensus was clear: digital transformation and rigorous compliance are the keys to competing on the world stage.
